Kilitch Net Income From Continuing Ops from 2010 to 2024
| KILITCH Stock | 310.05 3.95 1.29% |
Net Income From Continuing Ops | First Reported 2014-06-30 | Previous Quarter 36.8 M | Current Value 1.1 M | Quarterly Volatility 20.2 M |
Check Kilitch Drugs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kilitch Drugs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 32.6 M, Interest Expense of 62.3 M or Selling General Administrative of 24.7 M, as well as many indicators such as . Kilitch financial statements analysis is a perfect complement when working with Kilitch Drugs Valuation or Volatility modules.
Kilitch | Net Income From Continuing Ops |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kilitch Stock
Kilitch Drugs financial ratios help investors to determine whether Kilitch Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kilitch with respect to the benefits of owning Kilitch Drugs security.